Samuel Murphy is the founder of SalubrisBio. SalubrisBio has raised $67M in total funding. Latest round: Series A. Based in Gaithersburg, United States.
Samuel Murphy is a co-founder and Chief Executive Officer of Salubris Biotherapeutics (SalubrisBio), a clinical-stage biotechnology company based in Gaithersburg, Maryland, which he founded in 2016 with John Li. He formerly was a virologist from the University of Pennsylvania. Murphy leads the company's development of complex biologics for cardiovascular, oncology, and neurodegenerative diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library